The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ADInstruments sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
ADInstruments Pty Ltd (ADInstruments) develops and manufactures data acquisition and analysis equipment for life science research and education. The company’s key products include LabChart, PowerLab, LabTutor, complete data acquisition systems, signal conditioners, auxiliary instruments, transducers, accessories and parts, and consumables. It offers its products to universities, hospitals, research institutes, pharmaceutical companies, contract research organizations, and other private companies. ADInstruments conducts research and development in the areas of electrophysiology, exercise and sports science, muscle, cardiovascular, nervous and sensory, respiratory and tissue, and circulation, among others. The company distributes products through a network of distributors in Australia and other countries. It also provides education, training, and support services. ADInstruments is headquartered in Bella Vista, New South Wales, Australia. Key subsidiaries of ADInstruments include ADInstruments Shanghai Trading, ADInstruments, ADInstruments South Asia ( India ), ADInstruments Japan and ADInstruments do Brasil.
The key metrics of ADInstruments related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As ADInstruments is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ADInstruments.
For a detailed understanding of the performance of ADInstruments, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.